3 active not recruiting. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 3 |
| Phase 1 | 2 | Active not recruiting 2 |
Follow Endoscopy: new trials by email Literature Review of Endoscopy trials Research Report on Endoscopy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, Biospecimen Collection, Endoscopic Biopsy - Colorectal Carcinoma, Lynch Syndrome | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 45 | 2022-11-10 | 2026-03-03 |
| Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer Carboplatin, Endoscopic Biopsy, External Beam Radiation Therapy - Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 2 | Active not recruiting | City of Hope Medical Center | 3 | 2022-01-25 | 2026-06-23 |
| Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma Lenalidomide, Rituximab, Prednisone - Primary Effusion Lymphoma, B-Cell Neoplasm | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 17 | 2017-07-03 | 2026-10-20 |
Adenocarcinoma Of Esophagus (1) · Colorectal Neoplasms (1) · Colorectal Neoplasms, Hereditary Nonpolyposis (1) · Esophageal Squamous Cell Carcinoma (1) · Lymphoma, AIDS-Related (1) · Lymphoma, B-Cell (1) · Lymphoma, Primary Effusion (1)
National Cancer Institute (NCI) (2) · City of Hope Medical Center (1)
United States (3) · Puerto Rico (1)
Eduardo Vilar-Sanchez (1) · Ramya Ramaswami, MBBS, MPH (1) · Vincent Chung, MD (1)
P30CA016672 (1), P30CA033572 (1), UG1CA242609 (1)